Leon O. Moulder's most recent trade in Zai Lab Limited - ADR was a trade of 22,371 American Depositary Shares done . Disclosure was reported to the exchange on June 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Ltd (ADR) | Leon Oliver Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 22,371 | 94,973 (0%) | 0% | 0 | American Depositary Shares | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.88 per share. | 18 May 2026 | 60,000 | 96,928 | - | 16.9 | 1,012,800 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 17.62 per share. | 28 Apr 2026 | 35,000 | 1,786,039 | - | 17.6 | 616,700 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 18.02 per share. | 28 Apr 2026 | 25,000 | 1,751,039 | - | 18.0 | 450,500 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.31 per share. | 30 Mar 2026 | 34,000 | 1,726,039 | - | 19.3 | 656,540 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 18.23 per share. | 30 Mar 2026 | 20,000 | 1,692,039 | - | 18.2 | 364,600 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 17.96 per share. | 02 Feb 2026 | 57,000 | 423,155 | - | 18.0 | 1,023,720 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.38 per share. | 07 Jan 2026 | 50,000 | 316,155 | - | 16.4 | 819,000 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.30 per share. | 07 Jan 2026 | 30,000 | 346,155 | - | 16.3 | 489,000 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.55 per share. | 07 Jan 2026 | 20,000 | 366,155 | - | 16.6 | 331,000 | Common Stock |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 20.85 per share. | 07 Oct 2025 | 36,928 | 36,928 | - | 20.9 | 769,949 | Common Stock |
| Zai Lab Ltd (ADR) | Leon Oliver Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 72,602 (0%) | 0% | 0 | American Depositary Shares | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Leon Moulder Oliver | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 18 Feb 2025 | 25,000 | 266,155 | - | 6.7 | 166,750 | Common Stock |
| Zai Lab Ltd (ADR) | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 61,771 (0%) | 0% | 0 | American Depositary Shares | |
| Dianthus Therapeutics Inc | Leon O. Moulder | Director | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | ||
| Dianthus Therapeutics Inc | Leon O. Moulder | Director | 22 Jan 2024 | 166,667 | 1,436,745 | - | 12 | 2,000,004 | Common Stock | |
| Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |